Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Mediclinic International stock price, quote, forecast and news

MDC.L
GB00B8HX8Z88
A1W0TP

Price

5.01
Today +/-
+0
Today %
+0 %
P

Mediclinic International stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Mediclinic International stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Mediclinic International stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Mediclinic International stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Mediclinic International's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Mediclinic International Stock Price History

DateMediclinic International Price
5/26/20235.01 undefined
5/25/20235.00 undefined

Mediclinic International Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Mediclinic International, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Mediclinic International from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Mediclinic International’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Mediclinic International. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Mediclinic International’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Mediclinic International’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Mediclinic International’s growth potential.

Mediclinic International Revenue, EBIT and net profit per share

DateMediclinic International RevenueMediclinic International EBITMediclinic International Net Income
2027e4.13 B undefined457.1 M undefined311.59 M undefined
2026e3.86 B undefined412.11 M undefined269.22 M undefined
2025e3.83 B undefined400.4 M undefined254.92 M undefined
2024e3.69 B undefined382 M undefined231.92 M undefined
2023e3.58 B undefined357.41 M undefined206.38 M undefined
20223.23 B undefined273 M undefined151 M undefined
20213 B undefined202 M undefined68 M undefined
20203.08 B undefined325 M undefined-320 M undefined
20192.93 B undefined325 M undefined-151 M undefined
20182.88 B undefined354 M undefined-492 M undefined
20172.75 B undefined364 M undefined229 M undefined
20162.11 B undefined289 M undefined177 M undefined
20151.98 B undefined321 M undefined241 M undefined
2014272.8 M undefined51.9 M undefined49.3 M undefined
2013233.5 M undefined48 M undefined39.3 M undefined
2012204.7 M undefined38.9 M undefined38.2 M undefined
2011182.7 M undefined31.4 M undefined31.7 M undefined
2010156.3 M undefined24.5 M undefined24.7 M undefined

Mediclinic International Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
20102011201220132014201520162017201820192020202120222023e2024e2025e2026e2027e
0.160.180.20.230.271.982.112.752.882.933.0833.233.583.693.833.864.13
-16.6712.0914.2216.74626.846.5830.474.621.955.15-2.857.9510.793.043.850.736.84
39.7440.1141.6742.0642.6540.1140.0138.3038.1437.6936.43-------
0.060.070.090.10.120.790.841.051.11.111.120000000
2431384851321289364354325325202273357382400412457
15.3817.0318.6320.6018.7516.2413.7213.2412.3111.0810.546.748.449.9710.3510.4410.6711.08
2431383949241177229-492-151-32068151206231254269311
-29.1722.582.6325.64391.84-26.5629.38-314.85-69.31111.92-121.25122.0636.4212.149.965.9115.61
------------------
------------------
116.9116.9116.9109.2117.3550.23599.21737.24737.11737.19737.21737.24737.2400000
------------------
Details

Keystats

ⓘ

Revenue and Growth

The Mediclinic International Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Mediclinic International is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
2010201120122013201420152016201720182019202020212022
                         
23.939.537.66562265305377262266331296540
38.342.545.251.974.1293380425440516562718722
2.23.43.80.70.51241691681682171686256
6.69.28.81013.1607590908810410997
2.93.22.70002914484759
0.070.10.10.130.150.740.931.070.961.091.211.231.47
0.020.010.010.020.042.993.23.73.593.524.364.054.39
000009461473364203190183189
0000000000000
0004.67.1333409441153136124115119
0000.010.010.311.531.721.251.451.050.951.01
0000.11.818172122232214433
0.020.010.010.030.063.655.626.355.385.345.745.445.73
0.090.110.110.160.214.46.557.426.346.436.956.677.21
                         
00010.911.699474747474747474
454.24560418.9445.40690690690690690690690
-0.41-0.39-0-0.32-0.310.812.753.322.522.391.321.521.59
0000000000807570750
0000000000000
0.050.07-00.110.151.83.514.093.293.152.892.853.11
18.419.227.438.343.5157200227210230260235263
8.413.70005464807254576065
6.55.631.63.9163206214172215239243324
1.11.100.1000000000
0017.90068317697187213146171
34.439.648.34047.4442787590525586769684823
000.06001.551.521.961.871.92.442.312.42
00000429446527467423427425432
3.95.55.38.210.3135222180112258314289288
0.010.010.060.010.012.112.192.672.452.583.183.023.14
0.040.050.110.050.062.562.983.262.973.163.953.713.96
0.090.110.110.160.214.366.497.356.266.316.846.557.07
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Mediclinic International provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Mediclinic International's financial health and stability.

Assets

Mediclinic International's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Mediclinic International must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Mediclinic International after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Mediclinic International's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (k)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2010201120122013201420152016201720182019202020212022
2431383951266245307-479-137-275104211
455578593145168168217217228
0000000000000
-5-3-141-13-75-76-141-197-171-105-2092
11392615883853484619123113
001305755777461837069
000005245455655592946
2535335548337320394345344456235554
-5-5-4-12-2000000000
-4-4-7-10-47-257-1,549-218-319-298-182-137-189
00-3,0001,000-27,000-257,000-1.55 M-218,000-319,000-298,000-182,000-137,000-189,000
0000000000000
0-179-820-138217-80-2438-131-120-136
0000.1001.09000000
-0.02-0.02-0.03-0.01-0.02-0.021.24-0.17-0.11-0.03-0.21-0.13-0.15
---3.00-12.00--14.00-17.00-27.00-26.00-13.00-17.00-10.00-13.00
-13-14-105-13-15-47-48-62-58-59-5900
514-333-15674056-100464-35240
20.330.428.842.827.9337320394345344456235554
0000000000000

Mediclinic International stock margins

The Mediclinic International margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Mediclinic International. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Mediclinic International.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Mediclinic International's sales revenue. A higher gross margin percentage indicates that the Mediclinic International retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Mediclinic International's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Mediclinic International's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Mediclinic International's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Mediclinic International. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Mediclinic International's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Mediclinic International Margin History

Mediclinic International Gross marginMediclinic International Profit marginMediclinic International EBIT marginMediclinic International Profit margin
2027e36.43 %11.08 %7.55 %
2026e36.43 %10.67 %6.97 %
2025e36.43 %10.45 %6.65 %
2024e36.43 %10.35 %6.28 %
2023e36.43 %9.98 %5.76 %
202236.43 %8.44 %4.67 %
202136.43 %6.74 %2.27 %
202036.43 %10.54 %-10.38 %
201937.69 %11.08 %-5.15 %
201838.14 %12.31 %-17.11 %
201738.3 %13.24 %8.33 %
201640.01 %13.72 %8.4 %
201540.11 %16.24 %12.19 %
201442.74 %19.02 %18.07 %
201342.31 %20.56 %16.83 %
201241.82 %19 %18.66 %
201140.18 %17.19 %17.35 %
201040.05 %15.67 %15.8 %

Mediclinic International Stock Sales Revenue, EBIT, Earnings per Share

The Mediclinic International earnings per share therefore indicates how much revenue Mediclinic International has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Mediclinic International earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Mediclinic International's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Mediclinic International’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Mediclinic International's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Mediclinic International Revenue, EBIT and net profit per share

DateMediclinic International Sales per ShareMediclinic International EBIT per shareMediclinic International Earnings per Share
2027e5.6 undefined0 undefined0.42 undefined
2026e5.24 undefined0 undefined0.37 undefined
2025e5.2 undefined0 undefined0.35 undefined
2024e5.01 undefined0 undefined0.31 undefined
2023e4.86 undefined0 undefined0.28 undefined
20224.39 undefined0.37 undefined0.2 undefined
20214.06 undefined0.27 undefined0.09 undefined
20204.18 undefined0.44 undefined-0.43 undefined
20193.98 undefined0.44 undefined-0.2 undefined
20183.9 undefined0.48 undefined-0.67 undefined
20173.73 undefined0.49 undefined0.31 undefined
20163.52 undefined0.48 undefined0.3 undefined
20153.59 undefined0.58 undefined0.44 undefined
20142.33 undefined0.44 undefined0.42 undefined
20132.14 undefined0.44 undefined0.36 undefined
20121.75 undefined0.33 undefined0.33 undefined
20111.56 undefined0.27 undefined0.27 undefined
20101.34 undefined0.21 undefined0.21 undefined

Mediclinic International business model

Mediclinic International PLC is a leading global healthcare provider that treats patients in a variety of medical specialties. The company was founded in South Africa in 1983 and has since grown steadily. Today, it is represented in various countries such as South Africa, the United Kingdom, and the United Arab Emirates. Mediclinic's business model is based on providing its patients with high-quality medical care. The company operates various clinics and facilities that are specifically tailored to the needs of patients. These include general clinics, specialty clinics, and clinics specialized in treating certain diseases or patient groups. Under the Mediclinic International PLC umbrella, there are various divisions that cover different medical services. One important division is Mediclinic Southern Africa, which focuses on providing healthcare services in South Africa. In this segment, the company operates several hospitals, clinics, and medical facilities that all operate at a high level. Another important division is Mediclinic Middle East, which focuses on caring for patients in the United Arab Emirates. The company operates several clinics that specialize in various medical specialties. These include clinics for pediatrics, orthopedics, and neurology, as well as clinics specializing in the treatment of cancer and other serious illnesses. A third important division of Mediclinic is Mediclinic Switzerland, which operates various clinics and medical facilities in Switzerland. Here, the company focuses primarily on providing high-quality medical services in areas such as orthopedics and oncology. In addition to the various divisions, Mediclinic also operates a range of products targeting patients and medical professionals. These include various medical devices used in the diagnosis and treatment of patients. Furthermore, the company also offers a range of medical training and continuing education programs to support and keep medical professionals up to date. Overall, Mediclinic International PLC aims to provide patients in different countries and medical specialties with the best possible care. The company operates a variety of clinics and facilities, each operating at a high level. Additionally, Mediclinic offers a range of products and medical training to support both patients and professionals. Mediclinic International is one of the most popular companies on Eulerpool.com.

Mediclinic International SWOT Analysis

Strengths

Mediclinic International PLC has multiple strengths that contribute to its competitive advantage and success in the healthcare industry. These strengths include:

  • Strong Brand Reputation: Mediclinic International PLC is recognized as a trusted and reliable provider of quality healthcare services, which helps attract and retain patients.
  • Global Presence: The company operates in several countries and has a wide geographical footprint, providing it with diverse revenue streams and opportunities for growth.
  • Comprehensive Service Portfolio: Mediclinic International PLC offers a broad range of medical specialties and services, ensuring it can meet the diverse healthcare needs of patients.
  • Skilled Healthcare Professionals: The organization employs highly qualified doctors, nurses, and medical staff, enabling it to deliver excellent patient care and achieve positive health outcomes.
  • Technological Advancements: Mediclinic International PLC invests in state-of-the-art medical technology, enhancing its diagnostic and treatment capabilities, and staying ahead of competitors.

Weaknesses

Despite its strengths, Mediclinic International PLC also faces certain weaknesses that need to be addressed to maintain its market position. These weaknesses include:

  • Cost Structure: The company's cost structure is relatively high, leading to higher prices for its healthcare services, which may deter cost-sensitive patients or limit market reach.
  • Dependency on Regulations: Mediclinic International PLC operates in a highly regulated industry, making it susceptible to changes in healthcare policies, government regulations, and reimbursement systems.
  • Integration Challenges: The company's expansion into new geographic markets through acquisitions may present integration challenges, including cultural differences and operational synergies.

Opportunities

Mediclinic International PLC has several opportunities to capitalize on and further grow its business. These opportunities include:

  • Emerging Markets: Expansion into emerging markets, where healthcare services are in high demand but less saturated, can provide significant growth opportunities for the company.
  • Aging Population: The increasing elderly population worldwide presents an opportunity for Mediclinic International PLC to offer specialized geriatric care and related services.
  • Technological Innovations: The advancements in healthcare technology, such as telemedicine and wearable devices, offer opportunities for the company to enhance patient care delivery and improve operational efficiency.

Threats

Despite its strong market position, Mediclinic International PLC faces certain threats that may impact its business operations. These threats include:

  • Intense Competition: The healthcare industry is highly competitive, with the presence of both large hospital networks and smaller local providers, posing a threat to the company's market share.
  • Economic Uncertainty: Economic downturns or fluctuations in the countries where Mediclinic International PLC operates can affect patient volumes, making it challenging to maintain revenue growth.
  • Changing Healthcare Trends: Changing patient preferences, increased demand for alternative medicine, and shifts in healthcare delivery models pose threats to the traditional hospital-based care provided by Mediclinic International PLC.

Mediclinic International Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Mediclinic International historical P/E ratio, EBIT, and P/S ratio.

Mediclinic International shares outstanding

The number of shares was Mediclinic International in 2023 — This indicates how many shares 737.244 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Mediclinic International earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Mediclinic International's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Mediclinic International’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Mediclinic International's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Mediclinic International dividend history and estimates

In 2023, Mediclinic International paid a dividend amounting to 0.57 GBP. Dividend means that Mediclinic International distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Mediclinic International provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Mediclinic International’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Mediclinic International's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Mediclinic International Dividend History

DateMediclinic International Dividend
2027e0.03 undefined
2026e0.03 undefined
2025e0.03 undefined
2024e0.03 undefined
2023e0.03 undefined
20220.03 undefined
20190.08 undefined
20180.08 undefined
20170.08 undefined
20163.73 undefined
20150.15 undefined
20140.14 undefined

Mediclinic International dividend payout ratio

In 2023, Mediclinic International had a payout ratio of 202.29%. The payout ratio indicates the percentage of the company's profits that Mediclinic International distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Mediclinic International represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Mediclinic International could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Mediclinic International's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Mediclinic International Payout Ratio History

DateMediclinic International Payout ratio
2027e128.69 %
2026e147.09 %
2025e113.98 %
2024e125 %
2023e202.29 %
202214.65 %
2021158.07 %
2020434.14 %
2019-38.57 %
2018-11.84 %
201725.43 %
20161,262.34 %
201533.23 %
201433.6 %
2013434.14 %
2012434.14 %
2011434.14 %
2010434.14 %
Unfortunately, there are currently no price targets and forecasts available for Mediclinic International.

Mediclinic International latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20220.1 0.09  (-8.08 %)2023 Q2
3/31/20220.12 0.12  (-3.28 %)2022 Q4
9/30/20210.09 0.11  (14.16 %)2022 Q2
3/31/20210.06 0.11  (93.22 %)2021 Q4
9/30/20200 0.02  (411.11 %)2021 Q2
3/31/20200.09 0.14  (63.95 %)2020 Q4
9/30/20190.24 0.1  (-59.06 %)2020 Q2
3/31/20190.19 0.17  (-12.95 %)2019 Q4
9/30/20160.15 0.13  (-16.99 %)2017 Q2
1

Mediclinic International list of shareholders

%
Name
Stocks
Change
Date
9.43837 % Public Investment Corporation (SOC) Limited69,571,203-211,8103/13/2023
44.56563 % Remgro Ltd328,497,88806/22/2022
3.65362 % Standard Bank Group Ltd26,931,19226,931,1927/7/2022
3.42881 % Société Générale Securities Services S.A.25,274,108-2,785,2383/13/2023
2.44137 % The Vanguard Group, Inc.17,995,614-16,8083/9/2023
2.11434 % Barclays Wealth15,585,0134,045,5283/13/2023
2.03459 % Dimensional Fund Advisors, L.P.14,997,187241,6112/13/2023
1.97987 % Ninety One SA Pty Ltd.14,593,837-3,4503/9/2023
1.84731 % Ostrum Asset Management13,616,705-5,762,0003/6/2023
1.73899 % UBS O'Connor LLC12,818,291293,5583/3/2023
1
2
3
4
5
...
10

Mediclinic International Executives and Management Board

Dr. Ronnie Van Der Merwe57
Mediclinic International Group Chief Executive Officer, Executive Director
Compensation 1.52 M
Mr. Jurgens Myburgh
Mediclinic International Group Chief Financial Officer, Executive Director (since 2016)
Compensation 1 M
Ms. Dame Inga Beale58
Mediclinic International Non-Executive Chairman of the Board
Compensation 280,000
Mr. Steve Weiner
Mediclinic International Non-Executive Independent Director
Compensation 94,000
Dr. Felicity Harvey
Mediclinic International Senior Independent Non-Executive Director
Compensation 92,000
1
2
3
4
...
5

Mediclinic International Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Norcros Stock
Norcros
SupplierCustomer0,840,04-0,52-0,71-0,55-
Spire Healthcare Group Stock
Spire Healthcare Group
SupplierCustomer0,69-0,09-0,11-0,400,100,72
Remgro Stock
Remgro
SupplierCustomer-0,57-0,14-0,52-0,69-0,530,45
1

Most common questions regarding Mediclinic International

What values and corporate philosophy does Mediclinic International represent?

Mediclinic International PLC embodies a set of core values and a corporate philosophy that underpin its operations. As a leading private healthcare provider, Mediclinic strives for clinical excellence and quality patient care. With a strong focus on ethical conduct and professionalism, the company is committed to fostering a culture of compassion, respect, and integrity. Mediclinic values the diversity of its people and promotes open communication, collaboration, and teamwork across its global network of hospitals and clinics. Through its patient-centric approach, cutting-edge technology, and continuous innovation, Mediclinic International PLC remains dedicated to delivering exceptional healthcare services to its communities worldwide.

In which countries and regions is Mediclinic International primarily present?

Mediclinic International PLC is primarily present in three countries: South Africa, Switzerland, and the United Arab Emirates. In South Africa, it operates a network of private hospitals and clinics, offering a broad range of healthcare services. In Switzerland, Mediclinic focuses on acute care private hospitals and clinics, providing specialized medical services. The company has established a strong presence in the United Arab Emirates as well, operating state-of-the-art hospitals and clinics. With operations in these key markets, Mediclinic International PLC demonstrates its commitment to delivering high-quality healthcare services across multiple countries and regions.

What significant milestones has the company Mediclinic International achieved?

Mediclinic International PLC has achieved several significant milestones in its history. The company successfully expanded its network by acquiring Al Noor Hospitals Group in 2016, entering the Middle East market. Additionally, Mediclinic became the first major international private healthcare provider to list on the London Stock Exchange and the Johannesburg Stock Exchange in 2016. The company operates a diverse portfolio of hospitals and clinics across Southern Africa, Switzerland, and the United Arab Emirates. Mediclinic International PLC focuses on delivering high-quality healthcare services to patients and continues to grow its global presence through strategic acquisitions and partnerships.

What is the history and background of the company Mediclinic International?

Mediclinic International PLC, headquartered in London, is a leading private healthcare provider with operations across the globe. The company has a rich history that dates back to 1983 when the first Mediclinic was established in South Africa. Since then, Mediclinic has expanded its footprint through strategic acquisitions and organic growth, establishing a strong presence in Switzerland and the United Arab Emirates. With a focus on delivering high-quality healthcare services, Mediclinic offers a comprehensive range of inpatient and outpatient services, including acute care, specialist-orientated, and multidisciplinary healthcare. The company's commitment to clinical excellence and patient-centric care has earned it a reputation as a trusted healthcare provider worldwide.

Who are the main competitors of Mediclinic International in the market?

The main competitors of Mediclinic International PLC in the market include companies such as HCA Healthcare, Ramsay Health Care, and Fresenius SE & Co. KGaA.

In which industries is Mediclinic International primarily active?

Mediclinic International PLC is primarily active in the healthcare industry.

What is the business model of Mediclinic International?

Mediclinic International PLC operates as a private hospital group, delivering high-quality healthcare services. The company provides both inpatient and outpatient services, including acute care, specialized surgery, diagnostic imaging, and emergency medical services. Mediclinic International PLC aims to enhance patient outcomes through medical expertise, modern technology, and personalized care. The company operates across three divisions: Mediclinic Southern Africa, Mediclinic Middle East, and Mediclinic Switzerland. By offering advanced medical treatments and maintaining a patient-centric approach, Mediclinic International PLC strives to be a leading provider of healthcare services worldwide.

What is the P/E ratio of Mediclinic International 2024?

The Mediclinic International P/E ratio is 15.93.

What is the P/S ratio of Mediclinic International 2024?

The Mediclinic International P/S ratio is 1.

What is the AlleAktien quality score of Mediclinic International?

The AlleAktien quality score for Mediclinic International is 4/10.

What is the revenue of Mediclinic International 2024?

The expected Mediclinic International revenue is 3.69 B GBP.

How high is the profit of Mediclinic International 2024?

The expected Mediclinic International profit is 231.92 M GBP.

What is the business model of Mediclinic International

Mediclinic International PLC is a globally operating company in the healthcare sector that specializes in providing high-quality medical services. The business model of Mediclinic is based on its three-pronged strategy, which includes the hospital business, the outpatient business, and the diagnostic imaging business. Each division of the company offers a wide range of products and services to meet the needs of its customers. The hospital business of Mediclinic includes the management of hospitals in South Africa, Switzerland, and the United Arab Emirates. These hospitals are equipped with state-of-the-art technology and highly qualified professionals to provide comprehensive care for patients. The hospitals offer a wide range of services, such as general surgery, neurosurgery, cardiology, gastroenterology, obstetrics and gynecology, oncology, and orthopedics. The outpatient business of Mediclinic includes a variety of clinics and medical practices in South Africa, the United Arab Emirates, and Switzerland. Specialized areas such as ophthalmology, ENT, dermatology, gynecology, and obstetrics are covered here. The clinics also offer health services such as health monitoring, preventive health checks, and vaccinations. Mediclinic's diagnostic imaging business offers modern imaging services, including magnetic resonance imaging (MRI), computed tomography (CT), X-ray, and ultrasound. These services are available to patients in Mediclinic's hospitals and clinics, allowing for appropriate diagnosis and treatment. Modern equipment in the imaging centers enables doctors to quickly and safely create even complex clinical images. Mediclinic is committed to always providing its customers with the best medical services and is guided by its principles. The company continuously works to improve the quality and safety of its medical services and ensure effective workflows. Overall, the business model of Mediclinic International PLC is focused on providing its customers with competent, high-quality medical services. The company holds a leading position in the healthcare sector and remains committed to expanding its reach globally. With its diverse range of products and services worldwide, Mediclinic is an important player in global healthcare.

What is the Mediclinic International dividend?

Mediclinic International pays a dividend of 0.03 GBP distributed over payouts per year.

How often does Mediclinic International pay dividends?

The dividend cannot currently be calculated for Mediclinic International or the company does not pay out a dividend.

What is the Mediclinic International ISIN?

The ISIN of Mediclinic International is GB00B8HX8Z88.

What is the Mediclinic International WKN?

The WKN of Mediclinic International is A1W0TP.

What is the Mediclinic International ticker?

The ticker of Mediclinic International is MDC.L.

How much dividend does Mediclinic International pay?

Over the past 12 months, Mediclinic International paid a dividend of 0.03 GBP . This corresponds to a dividend yield of about 0.6 %. For the coming 12 months, Mediclinic International is expected to pay a dividend of 0.03 GBP.

What is the dividend yield of Mediclinic International?

The current dividend yield of Mediclinic International is 0.6 %.

When does Mediclinic International pay dividends?

Mediclinic International pays a quarterly dividend. This is distributed in the months of January, July, January, September.

How secure is the dividend of Mediclinic International?

Mediclinic International paid dividends every year for the past 6 years.

What is the dividend of Mediclinic International?

For the upcoming 12 months, dividends amounting to 0.03 GBP are expected. This corresponds to a dividend yield of 0.59 %.

In which sector is Mediclinic International located?

Mediclinic International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mediclinic International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mediclinic International from 8/26/2022 amounting to 0.03 GBP, you needed to have the stock in your portfolio before the ex-date on 8/4/2022.

When did Mediclinic International pay the last dividend?

The last dividend was paid out on 8/26/2022.

What was the dividend of Mediclinic International in the year 2023?

In the year 2023, Mediclinic International distributed 0.03 GBP as dividends.

In which currency does Mediclinic International pay out the dividend?

The dividends of Mediclinic International are distributed in GBP.

All fundamentals about Mediclinic International

Our stock analysis for Mediclinic International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediclinic International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.